Literature DB >> 33386495

Circ_0001247 functions as a miR-1270 sponge to accelerate cervical cancer progression by up-regulating ZEB2 expression level.

Wenshuang Wang1, Anli Xu1, Manyin Zhao1, Jianan Sun1, Lingyun Gao2.   

Abstract

BACKGROUND: There is increasing evidence that circular RNA (circRNA) disorders have an impact on the progression of various malignancies. The expression characteristics, function and underlying mechanism of circ_0001247 in cervical cancer (CC) have not been confirmed.
METHODS: GSE147483 datasets of circRNAs expression in CC cell line and normal cervical cell line were retrieved from GEO database, and the circRNA with significant difference was selected; circ_0001247, miR-1270, and Zinc finger E-box binding homeobox 2 (ZEB2) expressions in CC tissues and cell lines were analyzed by quantitative real-time polymerase chain reaction (qRT-PCR) assay; cell counting kit-8 (CCK-8) assay and BrdU assay were applied to monitor the proliferative ability of CC cells; Transwell assay was conducted to examine the migration and invasion of CC cells, and flow cytometry was used to evaluate the apoptosis; Western blot assay was adopted to detect ZEB2 protein expressions; dual-luciferase report gene assay was used to verify the targeting relationship between circ_0001247 and miR-1270, and miR-1270 and the 3'UTR of ZEB2.
RESULTS: Analysis of GSE147483 suggested that circ_0001247 could probably be an oncogenic circRNA in CC. Compared with that in adjacent tissues and normal cervical epithelial cells, circ_0001247 expression in CC tissues and cell lines was significantly increased; knocking down circ_0001247 expression could inhibit the proliferation and metastasis of CC cells, and promote apoptosis, while circ_0001247 overexpression worked oppositely; circ_0001247 sponged miR-1270 in CC cells; miR-1270 diminished the promoting effect of circ_0001247 by inactivating the ZEB2.
CONCLUSION: Circ_0001247 promotes progression of CC by sponging miR-1270 to upregulate ZEB2 expression level.

Entities:  

Keywords:  Cervical cancer; ZEB2; circ_0001247; miR-1270

Year:  2021        PMID: 33386495     DOI: 10.1007/s10529-020-03059-w

Source DB:  PubMed          Journal:  Biotechnol Lett        ISSN: 0141-5492            Impact factor:   2.461


  36 in total

Review 1.  Regulation of circRNA biogenesis.

Authors:  Ling-Ling Chen; Li Yang
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

Review 2.  Role of Zeb2/Sip1 in neuronal development.

Authors:  Ekaterina Epifanova; Alexey Babaev; Andrew G Newman; Victor Tarabykin
Journal:  Brain Res       Date:  2018-09-25       Impact factor: 3.252

Review 3.  Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases.

Authors:  Tara A Berman; John T Schiller
Journal:  Cancer       Date:  2017-03-27       Impact factor: 6.860

4.  ZEB2, a master regulator of the epithelial-mesenchymal transition, mediates trophoblast differentiation.

Authors:  Sonia C DaSilva-Arnold; Che-Ying Kuo; Viralkumar Davra; Yvonne Remache; Peter C W Kim; John P Fisher; Stacy Zamudio; Abdulla Al-Khan; Raymond B Birge; Nicholas P Illsley
Journal:  Mol Hum Reprod       Date:  2019-02-01       Impact factor: 4.025

5.  CircRNA hsa_circ_100395 regulates miR-1228/TCF21 pathway to inhibit lung cancer progression.

Authors:  Daishi Chen; Wei Ma; Zhaoyang Ke; Fei Xie
Journal:  Cell Cycle       Date:  2018-09-13       Impact factor: 4.534

6.  MiRNA-206 inhibits proliferation of renal clear cell carcinoma by targeting ZEB2.

Authors:  X-F Chen; J-F Guo; J-F Xu; S-H Yin; W-L Cao
Journal:  Eur Rev Med Pharmacol Sci       Date:  2019-09       Impact factor: 3.507

7.  Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma.

Authors:  Ningning Cong; Ping Du; Anling Zhang; Fajuan Shen; Juan Su; Peiyu Pu; Tao Wang; Jie Zjang; Chunsheng Kang; Qingyu Zhang
Journal:  Oncol Rep       Date:  2013-01-31       Impact factor: 3.906

8.  Members of the microRNA-200 family are promising therapeutic targets in cancer.

Authors:  Ying Chen; Lei Zhang
Journal:  Exp Ther Med       Date:  2017-05-22       Impact factor: 2.447

9.  LncRNA PVT1 promotes ovarian cancer progression by silencing miR-214.

Authors:  Ying Chen; Hui Du; Lewen Bao; Wenxin Liu
Journal:  Cancer Biol Med       Date:  2018-08       Impact factor: 4.248

10.  Circular RNA circ-ZKSCAN1 inhibits bladder cancer progression through miR-1178-3p/p21 axis and acts as a prognostic factor of recurrence.

Authors:  Junming Bi; Hongwei Liu; Wei Dong; Weibin Xie; Qingqing He; Zijian Cai; Jian Huang; Tianxin Lin
Journal:  Mol Cancer       Date:  2019-09-03       Impact factor: 27.401

View more
  2 in total

1.  Oncogenic circular RNA circ_0007534 contributes to paclitaxel resistance in endometrial cancer by sponging miR-625 and promoting ZEB2 expression.

Authors:  Hanjie Yi; Yongqing Han; Shanfeng Li
Journal:  Front Oncol       Date:  2022-08-04       Impact factor: 5.738

2.  Knockdown of long non-coding RNA SNHG8 suppresses the progression of esophageal cancer by regulating miR-1270/BACH1 axis.

Authors:  Yonghong Wu; Yan Liang; Min Li; Haidong Zhang
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.